Alternate Health (AHGIF) Akcie Kurz

Alternate Health Corp. generates revenue through the manufacturing and distribution of pharmaceutical grade cannabis products across the United States. The company offers a range of products including topical creams, tinctures, and Hempnesic, a hemp-based pain management cream, targeting patients seeking treatment for pain, scars, and fungus. Its subsidiaries provide medical practice management software, clinical research services, and continuing education programs, while its software systems support CBD product distribution, hemp-derived extract manufacturing, blockchain tax collection, and electronic medical records (EMR) platforms. The firm's primary customers are patients requiring medical cannabis solutions, healthcare providers utilizing its management software, and institutions participating in clinical research and education programs. Through its diversified operations, Alternate Health Corp. serves both the consumer market for cannabis-based treatments and the healthcare sector for technology-driven patient care and research. Alternate Health Corp. leverages its subsidiaries, Alternate Health, Inc. and Alternate Health USA Inc., to expand its product offerings and operational reach. The company's revenue streams include direct sales of cannabis products, software licensing for medical practice management, and service-based income from clinical research and education programs.